Girard Partners Ltd. Abbott Laboratories Transaction History

Girard Partners Ltd.

$1.06 Billion
Q2 2024

A detailed history of Girard Partners Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Girard Partners Ltd. holds 25,698 shares of ABT stock, worth $2.98 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

25,698

Previous 27,255 5.71%

Holding current value

$2.98 Million

Previous $3.1 Million 13.79%

% of portfolio

0.25%

Previous 0.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $156,836 - $175,069	-1,557 Reduced 5.71%	25,698 $2.67 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $310,598 - $343,042	-2,836 Reduced 9.42%	27,255 $3.1 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $1.41 Million - $1.73 Million	-15,653 Reduced 34.22%	30,091 $3.31 Million
Q3 2023 Nov 02, 2023	SELL	$95.53 - $114.62 $2.79 Million - $3.34 Million	-29,177 Reduced 38.94%	45,744 $4.43 Million
Q2 2023 Aug 15, 2023	BUY	$100.78 - $112.29 $664,341 - $740,215	6,592 Added 9.65%	74,921 $8.17 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $232,754 - $273,966	2,403 Added 3.64%	68,329 $6.92 Million
Q4 2022 Jan 26, 2023	BUY	$95.06 - $111.52 $21,103 - $24,757	222 Added 0.34%	65,926 $0
Q3 2022 Oct 20, 2022	BUY	$96.76 - $112.03 $61,732 - $71,475	638 Added 0.98%	65,704 $6.36 Million
Q2 2022 Jul 26, 2022	SELL	$102.07 - $123.37 $69,713 - $84,261	-683 Reduced 1.04%	65,066 $7.07 Million
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $788,676 - $961,739	6,917 Added 11.76%	65,749 $7.78 Million
Q4 2021 Feb 02, 2022	SELL	$115.53 - $141.46 $79,715 - $97,607	-690 Reduced 1.16%	58,832 $8.28 Million
Q3 2021 Nov 01, 2021	BUY	$116.66 - $129.06 $6.12 Million - $6.77 Million	52,491 Added 746.57%	59,522 $7.03 Million
Q3 2021 Nov 01, 2021	SELL	$116.66 - $129.06 $6.26 Million - $6.93 Million	-53,684 Reduced 88.42%	7,031 $7.03 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $3,385 - $3,984	32 Added 0.05%	60,715 $7.04 Million
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $70,528 - $83,093	-648 Reduced 1.06%	60,683 $7.27 Million
Q4 2020 Feb 02, 2021	SELL	$105.0 - $114.42 $214,305 - $233,531	-2,041 Reduced 3.22%	61,331 $6.72 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $367,476 - $446,272	-4,010 Reduced 5.95%	63,372 $6.9 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $411,870 - $527,142	-5,379 Reduced 7.39%	67,382 $6.16 Million
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $223,262 - $326,470	3,554 Added 5.14%	72,761 $5.74 Million
Q4 2019 Feb 03, 2020	SELL	$78.51 - $87.4 $161,259 - $179,519	-2,054 Reduced 2.88%	69,207 $6.01 Million
Q3 2019 Nov 01, 2019	SELL	$81.84 - $88.74 $1.13 Million - $1.23 Million	-13,828 Reduced 16.25%	71,261 $5.96 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $291,447 - $339,915	-3,999 Reduced 4.49%	85,089 $7.16 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $365,137 - $441,450	-5,514 Reduced 5.83%	89,088 $7.12 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $470,065 - $532,515	-7,170 Reduced 7.05%	94,602 $6.84 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $178,598 - $215,458	-2,937 Reduced 2.8%	101,772 $7.47 Million
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $6.03 Million - $6.65 Million	104,709 New	104,709 $6.39 Million
Q1 2018 Apr 18, 2018	SELL	$56.27 - $63.62 $5.99 Million - $6.78 Million	-106,499 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$53.68 - $57.47 $50,942 - $54,539	949 Added 0.9%	106,499 $6.08 Million
Q3 2017 Nov 08, 2017	SELL	$48.06 - $53.64 $13,697 - $15,287	-285 Reduced 0.27%	105,550 $5.63 Million
Q2 2017 Aug 08, 2017	BUY	N/A	105,835	105,835 $5.15 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.

Account

Girard Partners Ltd. Abbott Laboratories Transaction History